Similar articles

• Long-acting injectable naltrexone for the treatment of alcohol dependence.

  Mannelli P, Peindl K, Masand PS, Patkar AA. Mannelli P, et al. Expert Rev Neurother. 2007 Oct;7(10):1265-77. doi: 10.1586/14737175.7.10.1265. Expert Rev Neurother. 2007. PMID: 17939765 Review.
• Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

  Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group. Garbutt JC, et al. JAMA. 2005 Apr 6;293(13):1617-25. doi: 10.1001/jama.293.13.1617. JAMA. 2005. PMID: 15811981 Clinical Trial.
• A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence.

  Johnson BA, Ait-Daoud N, Aubin HJ, Van Den Brink W, Guzzetta R, Loewy J, Silverman B, Ehrich E. Johnson BA, et al. Alcohol Clin Exp Res. 2004 Sep;28(9):1356-61. doi: 10.1097/01.alc.0000139823.30096.52. Alcohol Clin Exp Res. 2004. PMID: 15365306 Clinical Trial.
• Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery.

  Roozen HG, de Waart R, van den Brink W. Roozen HG, et al. Eur Addict Res. 2007;13(4):201-6. doi: 10.1159/000104882. Eur Addict Res. 2007. PMID: 17851241
• Naltrexone: Not Just for Opioids Anymore.

  Sudakin D. Sudakin D. J Med Toxicol. 2016 Mar;12(1):71-5. doi: 10.1007/s13181-015-0512-x. J Med Toxicol. 2016. PMID: 26546222 Free PMC article. Review.